CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Tanay Loya
/ Categories: Trending, Markets

Healthcare Global spurts post increase in FPI investment cap

Shares of Healthcare Global Enterprises shares zoomed over 7 per cent on the bourses on Friday. The Reserve Bank of India (RBI) increased the foreign investment limit for the company.

RBI  increased the foreign investment limit for foreign portfolios investors (FPIs) in the company from 24 per cent to 100 per cent of the paid-up capital of the company, on Thursday. 

The company has passed the necessary resolutions of its board of directors and general body for the same.Healthcare Global Enterprises is India's largest provider of cancer care with a network of 20 cancer care centres across India.

On Friday, Healthcare Global closed at Rs. 299.60 per share, up Rs. 21.25 or 7.63 per cent on NSE. The scrip opened at Rs. 288.00 and touched a high and Low of Rs. 304.95 and Rs. 288.00 per share, respectively, on NSE. The stock is trading 7 per cent lower than its 52-week high of Rs. 321. The stock attracted a traded volume of 3,09,935 shares on NSE. 

Previous Article Cadila Healthcare completes USFDA inspection of API plant
Next Article Asset Allocation: Mix It Right To Get Your Returns Right
Print
2049 Rate this article:
No rating
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR